Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: A 10-year cohort analysis

被引:324
作者
Sherman, ME
Lorincz, AT
Scott, DR
Wacholder, S
Castle, PE
Glass, AG
Mielzynska-Lohnas, I
Rush, BB
Schiffman, M
机构
[1] NCI, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, NIH, Bethesda, MD 20892 USA
[2] Digene Corp, Gaithersburg, MD USA
[3] Kaiser Permanente NW Div, Portland, OR USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2003年 / 95卷 / 01期
关键词
D O I
10.1093/jnci/95.1.46
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Annual Pap smear screening has been favored over less frequent screening in the United States to minimize the risk of cervical cancer. We evaluated whether simultaneous screening with a Pap test and human papillomavirus (HPV) testing is useful for assessing the risk for cervical intraepithelial neoplasia (CIN) 3 or cervical cancer. Methods: We enrolled 23 702 subjects in a study of HPV infection at Kaiser Permanente, Northwest Division, Portland, OR. Data were analyzed for 20810 volunteers who were at least 16 years old (mean = 35.9 years) with satisfactory baseline Pap tests and suitable samples for HPV testing. Women were followed for up to 122 months (from April 1, 1989, to June 30, 1999) to determine the risk for histopathologically confirmed CIN3 or cancer. Results: Among 171 women with CIN3 or cancer diagnosed over 122 months, 123 (71.9%, 95% confidence interval [CI] = 65.2% to 78.7%) had baseline Pap results of atypical squamous cells or worse and/or a positive HPV test, including 102 (86.4%, 95% CI = 80.3% to 92.6%) of the 118 cases diagnosed within the first 45 months of follow-up. During this 45-month period, the cumulative incidence of CIN3 or cancer was 4.54% (95% CI = 3.61% to 5.46%) among women with a Pap test result of atypical squamous cells or worse, positive HPV tests, or both compared with 0.16% (95% CI = 0.08% to 0.24%) among women with negative Pap and HPV tests. Age, screening behavior, a history of cervical cancer precursors, and a history of treatment for CIN minimally affected results. Conclusions: Negative baseline Pap and HPV tests were associated with a low risk for CIN3 or cancer in the subsequent 45 months, largely because a negative HPV test was associated with a decreased risk of cervical neoplasia. Negative combined test results should provide added reassurance for lengthening the screening interval among low-risk women, whereas positive results identify a relatively small subgroup that requires more frequent surveillance.
引用
收藏
页码:46 / 52
页数:7
相关论文
共 37 条
  • [1] PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE
    BOSCH, FX
    MANOS, MM
    MUNOZ, N
    SHERMAN, M
    JANSEN, AM
    PETO, J
    SCHIFFMAN, MH
    MORENO, V
    KURMAN, R
    SHAH, KV
    ALIHONOU, E
    BAYO, S
    MOKHTAR, HC
    CHICAREON, S
    DAUDT, A
    DELOSRIOS, E
    GHADIRIAN, P
    KITINYA, JN
    KOULIBALY, M
    NGELANGEL, C
    TINTORE, LMP
    RIOSDALENZ, JL
    SARJADI
    SCHNEIDER, A
    TAFUR, L
    TEYSSIE, AR
    ROLON, PA
    TORROELLA, M
    TAPIA, AV
    WABINGA, HR
    ZATONSKI, W
    SYLLA, B
    VIZCAINO, P
    MAGNIN, D
    KALDOR, J
    GREER, C
    WHEELER, C
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11): : 796 - 802
  • [2] Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors
    Burk, RD
    Kelly, P
    Feldman, J
    Bromberg, J
    Vermund, SH
    Dehovitz, JA
    Landesman, SH
    [J]. SEXUALLY TRANSMITTED DISEASES, 1996, 23 (04) : 333 - 341
  • [3] HPV testing in primary screening of older women
    Cuzick, J
    Beverley, E
    Ho, L
    Terry, G
    Sapper, H
    Mielzynska, I
    Lorincz, A
    Chan, WK
    Krausz, T
    Soutter, P
    [J]. BRITISH JOURNAL OF CANCER, 1999, 81 (03) : 554 - 558
  • [4] PERSISTENT GENITAL HUMAN PAPILLOMAVIRUS INFECTION AS A RISK FACTOR FOR PERSISTENT CERVICAL DYSPLASIA
    HO, GYF
    BURK, RD
    KLEIN, S
    KADISH, AS
    CHANG, CJ
    PALAN, P
    BASU, J
    TACHEZY, R
    LEWIS, R
    ROMNEY, S
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (18): : 1365 - 1371
  • [5] Natural history of cervicovaginal papillomavirus infection in young women
    Ho, GYF
    Bierman, R
    Beardsley, L
    Chang, CJ
    Burk, RD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (07) : 423 - 428
  • [6] Jacobs MV, 2000, INT J CANCER, V87, P221, DOI 10.1002/1097-0215(20000715)87:2&lt
  • [7] 221::AID-IJC11&gt
  • [8] 3.0.CO
  • [9] 2-2
  • [10] A COHORT STUDY OF THE RISK OF CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE-2 OR GRADE-3 IN RELATION TO PAPILLOMAVIRUS INFECTION
    KOUTSKY, LA
    HOLMES, KK
    CRITCHLOW, CW
    STEVENS, CE
    PAAVONEN, J
    BECKMANN, AM
    DEROUEN, TA
    GALLOWAY, DA
    VERNON, D
    KIVIAT, NB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (18) : 1272 - 1278